Top 5 IPOs of July 2026: SBI Funds, Manipal Health and More
India’s primary market saw five notable IPOs in July 2026, raising about ₹25,800.62 crore in proposed or completed funds. The largest was SBI Funds Management’s ₹9,812.91 crore OFS (July 14-16), priced ₹545-574, listed July 21 at ₹609.75. Other IPOs highlighted: Manipal Health Enterprises (₹9,275.22 crore), Indo-MIM (₹3,811.21 crore), Juniper Green Energy (₹1,800 crore) and Lohia Corp.
How this was made

The 30-second read
Why it matters
For traders, the most actionable elements are IPO subscription multiples and any immediate listing premium versus the issue price; for the remaining names, the excerpt provides offer schedules and bands but not demand outcomes.
Market read
This is primarily a primary-market calendar and demand snapshot; it supports short-term positioning around IPO pricing discovery and early trading reaction, especially for SBI Funds Management and Indo-MIM.
What to watch
For healthcare and manufacturing IPOs, valuation and integration/execution risks (debt servicing, acquisitions, customer concentration, export and currency exposure) may dominate after initial demand fades.
Background
The article is a listicle of five IPOs in India’s primary market during July 2026, highlighting issue size, subscription timing, and select demand metrics.
Ticker impact
SBI Funds Management IPO details include a ₹9,812.91 crore offer-for-sale, 41.66x subscription, and first-day close at ₹609.75 (+6.2%).
Bullish bias for the first days post-listing, with volatility tied to broader equity-market sentiment and mutual-fund flows.
The article provides hard IPO mechanics, subscription multiples, and the first trading-session close versus issue price, which are actionable for short-term positioning.
Indo-MIM IPO ran July 23-27 at ₹461-₹485, closed with ~72.34x overall subscription, and includes ~₹499.10 crore fresh issue for debt repayment.
Moderately bullish into listing, with risk from customer concentration and export/currency uncertainty highlighted in the text.
The article provides subscription multiples and use of proceeds, but lacks listing price or immediate market reaction.
Market effects
Read-across to India’s asset management, hospital operators, precision manufacturing, and renewable energy IPO appetite; demand signals may influence sentiment toward similar primary-market issuers.
Primarily India-focused primary-market flow narrative, with potential spillover into domestic small-cap and mid-cap sentiment during IPO weeks.
Limited direct global impact, but could marginally affect international investors’ India allocation decisions around IPO supply and demand.
Counterpoint
Offer-for-sale structures (notably SBI Funds Management) can dampen longer-term fundamentals, so strong subscription may not translate into sustained post-IPO outperformance.
Key entities
- issuerSBI Funds Management
IPO mechanics, subscription multiples, and first-session close versus issue price are provided.
- issuerManipal Health Enterprises
Fresh issue and offer-for-sale mix, debt reduction and minority stake acquisition plans are described.
- issuerIndo-MIM
Subscription multiples and use of fresh proceeds for debt repayment are provided.
- issuerJuniper Green Energy
IPO schedule and price band are provided, but subscription outcome is not in the excerpt.
- issuerLohia Corp
Named in the list, but the excerpt does not include IPO specifics.





